You are here

  • Home
  • Archive
  • Volume 31, Issue Suppl 3
  • 1196 A randomised phase II study of combination chemotherapy with nintedanib/placebo in advanced/recurrent endometrial cancer. FANDANGO/ENGOT-EN1/FANDANGO

Article metrics

Article menu

Download PDFPDF

Late breaking abstracts
Endometrial cancer
1196 A randomised phase II study of combination chemotherapy with nintedanib/placebo in advanced/recurrent endometrial cancer. FANDANGO/ENGOT-EN1/FANDANGO
Free

 

Online download statistics by month:

Online download statistics by month: October 2021 to April 2024

AbstractFullPdf
Oct 202133014
Nov 202155016
Dec 20213209
Jan 20229608
Feb 202215409
Mar 20222508
Apr 20222307
May 202230013
Jun 202278010
Jul 20225305
Aug 202242013
Sep 20223607
Oct 202241013
Nov 20224206
Dec 20227008
Jan 202340010
Feb 20236905
Mar 2023128016
Apr 202346012
May 20234003
Jun 20232606
Jul 202338015
Aug 20231805
Sep 20232806
Oct 202356010
Nov 202377014
Dec 202389011
Jan 20244807
Feb 20241202
Mar 202444010
Apr 20241504
Total15840282